Brain-Computer Interfaces & Neurotech

Blackrock Neurotech

by Blackrock Neurotech, Inc.

4.1
0

The industry-standard Utah Array neural interface powering decades of BCI research and clinical applications

Category

Brain-Computer Interfaces & Neurotech

Founded

2008

Headquarters

Salt Lake City, UT, USA

Overview

Blackrock Neurotech is the world's leading developer and manufacturer of intracortical neural interfaces, most notably the Utah Array — a 10x10 silicon microelectrode array that has become the gold standard for high-resolution neural recording in both research and clinical settings. The company also produces the NeuroPort Data Acquisition System for amplifying, filtering, and digitizing neural signals, and the CereStim multichannel neural stimulator for closed-loop applications. More than 30 human patients have received Blackrock implants under clinical trials, representing the largest number of chronically implanted BCI patients of any company. Neuroscience researchers at universities, national laboratories, and clinical research centers rely on Blackrock's systems to study motor control, sensory processing, and neural coding in non-human primates and human subjects. Clinical programs include motor BCI for paralysis (BrainGate consortium), sensory restoration, and treatment-resistant depression. The Utah Array's 96-channel resolution enables recording from individual neurons simultaneously across multiple cortical columns. Blackrock's competitive advantage lies in its unmatched track record in human implants: devices have remained functional in patients for over 10 years, demonstrating long-term biocompatibility and signal stability. The company's research-grade systems are deployed in over 400 labs worldwide, making it the reference platform for BCI science. Blackrock also offers the Neuroport Patient Cable system and supports closed-loop stimulation experiments critical for next-generation neuroprosthetics research.

Key Features

Adaptive Calibration

Self-calibrating algorithms adapt to neural signal changes over time without manual recalibration.

Biocompatible Materials

Advanced biocompatible coatings and materials minimize immune response and extend implant lifespan.

High-Density Neural Recording

Capture thousands of neurons simultaneously with ultra-thin electrode arrays and minimal tissue damage.

Real-Time Signal Processing

Millisecond-latency neural signal decoding for brain-to-device communication.

Wireless Neural Implants

Fully wireless implant design eliminates infection risks from percutaneous connectors.

Pros & Cons

Pros

  • +Machine learning decoders translate neural activity into device commands with 95%+ accuracy
  • +Wireless implant design eliminates infection risks associated with percutaneous connectors
  • +Real-time signal processing enables millisecond-latency brain-to-device communication
  • +High-density neural recording captures thousands of neurons simultaneously with minimal tissue damage
  • +Clinical trials demonstrate restoration of motor function for paralyzed patients
  • +Bidirectional interfaces support both neural recording and targeted neurostimulation

Cons

  • Limited patient population eligible for current-generation devices restricts market size
  • Signal degradation over time requires recalibration or potential device replacement
  • Regulatory pathway for novel neural interfaces is complex and evolving
  • Long-term biocompatibility and device longevity remain unproven beyond 5-10 year timeframes
  • Invasive implant procedures carry inherent surgical risks including infection and tissue damage

Use Cases

Research Workflow Optimization

AI-powered optimization of research workflows to accelerate discovery timelines and improve reproducibility.

Data Analysis & Insights

Machine learning analysis of complex biological datasets to extract actionable insights and identify patterns.

Collaboration & Knowledge Management

Platform-enabled collaboration across distributed research teams with integrated data sharing and knowledge capture.

Last updated: February 19, 2026